Amneal Pharmaceuticals (AMRX) Misses Q3 EPS by 5c; Offers FY22 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/29/2026
- Nasdaq futures slide as Alphabet results intensify AI spending fears
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
| AmerElite Solutions, Inc. New (NASDAQ: AMRX) | Delayed: 21.14 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $21.14 | 52 Week High | $0.19 | |||
| Open | $21.14 | 52 Week Low | $0.07 | |||
| Day High | $21.14 | P/E | N/A | |||
| Day Low | $21.14 | EPS | $-0.01 | |||
| Volume | 18,986 | |||||
